The News

Canopy Health Innovations Files a Suite of Additional Cannabis-Related Patents

April 23rd, 2018


TORONTO, April 23, 2018 /CNW/ – Canopy Health Innovations (“Canopy Health” or “CHI”), the partly-owned biopharmaceutical research and development affiliate of Canopy Growth Corporation (TSX: WEED) (“Canopy Growth”), today announced that it has, alone or with its subsidiary Canopy Animal Health or through its joint-venture Beckley Canopy Therapeutics, filed eight provisional US patents pertaining to

Learn more

Global Cannabis Research Leaders Beckley Foundation and Canopy Health Innovations Partner to Form Beckley Canopy Therapeutics

April 9th, 2018


SMITHS FALLS, ON and OXFORD, UK, April 9, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED) (“Canopy Growth”) is pleased to announce the launch of Beckley Canopy Therapeutics (“Beckley Canopy”), a partnership between its affiliate and biopharmaceutical research arm Canopy Health Innovations (“Canopy Health”) and drug research pioneer Lady Amanda Feilding and the Beckley Foundation

Learn more

Canopy Health Innovations Provides Operational Update: Provisional Patents Filed and Additional Funding Secured

September 27th, 2017


TORONTO, Sept. 27, 2017 /CNW/ – Canopy Health Innovations (“Canopy Health” or “CHI”) the partly-owned biopharmaceutical research and development subsidiary of Canopy Growth Corporation (TSX: WEED) (“Canopy Growth”), today announced that it has filed nine provisional patents pertaining to the applications of cannabis and cannabinoid based therapeutics in sleep and related nervous system disorders. The

Learn more

Canopy Health aims to evolve medical cannabis as a natural drug product and disrupt pharma market

June 20th, 2017


As president and CEO of newly formed Canopy Health Innovations, a spin off of Canopy Group (TSX:WEED), a world leading diversified cannabis company, Marc Wayne is a pioneer of the medical cannabis sector. He was a co-founder of Bedrocan Canada, one of Canada’s first licensed producers of medical cannabis, and founding chairman of the Cannabis

Learn more

Canopy Health Innovations President and Director Marc Wayne on the future of medical cannabis

June 5th, 2017


David Brown talks with Marc Wayne about his company’s plans for the future, and how the medical market will play out in the face of a recreational market Marc Wayne, President of Canopy Health Innovations, says Canada is entering a golden age in cannabis research, as access to supply and interest from the public and

Learn more

Canopy Health Innovations Enters into Agreement with Dr. Mark Ware

February 10th, 2017


SMITH FALLS, ON – Canopy Health Innovations (CHI), the recently formed research incubator partly owned by Canopy Growth Corporation (TSX: WEED), has entered into a 3-year consulting agreement with EPIC Consulting Inc., the Quebec-based consulting firm of Dr. Mark Ware. Canopy Health Innovations was established to research and develop clinically ready cannabis drug formulations and

Learn more

Canopy Health Innovations Closes Financing & Announces Leadership Appointment

December 21st, 2016


SMITHS FALLS, ON – Canopy Growth Corporation (TSX: CGC) (“Canopy Growth” or “CGC”) is pleased to announce that the recently formed Canopy Health Innovations (“CHI” or the “Corporation”), has closed an offering to sell common shares in the Corporation for gross proceeds of approximately $7 million. CHI will use the proceeds to establish general operations

Learn more

Canopy Health Innovations – Cannabis, Research and Intellectual Property Creation

December 2nd, 2016


SMITHS FALLS, ON – Canopy Growth Corporation (TSX: CGC) (“Canopy Growth” or the “Company”) is pleased to announce the formation of the cannabis research incubator, Canopy Health Innovations Inc. (“CHI”). The planning and implementation of the business strategy for CHI began in the summer of 2016, and CHI was formally incorporated as a private company

Learn more